Contrast media injectors are the radio-opaque injectors which allow injecting media into the body to enhance the visibility of tissues for a medical imaging procedure. Contrast media injectors which are used for injecting computed tomography iodine-based contrast agents are known as CT injectors.
Increasing prevalence of several chronic diseases such as cancer as well as cardiac, neurological, and orthopedic diseases amongst individuals are factors fuelling growth of the global contrast media injectors market. In addition, rising demand for minimally invasive surgeries is major factor driving growth target market. Furthermore, growing number of regulatory approvals for contrast media injectors, coupled with rapidly growing technological advancements in contrast media injectors are some other factors boosting growth of the global contrast media injectors market. However, adverse effects associated with contrast agents including iodinated contrast, barium, gadolinium, and micro bubble agents decreases their adoption by healthcare professionals are limiting the growth of target market.
Request Sample Copy: https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/445
Key players operating in the global contrast media injectors market includes
- Bracco Imaging S.p.A.,
- Guerbet Group LLC.,
- MEDTRON AG.,
- Bayer HealthCare LLC.,
- ulrich GmbH & Co. KG.,
- GE Corp.,
- VIVID IMAGING Pvt. Ltd.,
- Sino Medical Sciences Technology Inc.,
- Angio Dynamics Inc.,
- Apollo RT Co. Ltd.,
- Nemoto Kyorindo Co. Ltd.
Mr. Alex (Sales Manager)
Prophecy Market Insights
Phone: +1 860 531 2701 / +91 777 504 9802